描述
About Us
About Sequanta Technologies
Headquartered in the Waigaoqiao Bonded Area of China (Shanghai) Pilot Free Trade Zone, and equipped with a central laboratory spanning over 3000 m², as well as large-scale high-throughput sequencing platforms, Sequanta Technologies is a development, validation and testing analysis service provider capable of conducting over 300 CLIA/CAP/ISO15189 compliant, flexible, and customized professional tests. The company, with its outstanding sequencing technology, has expanded its service coverage from conventional genomics and transcriptomics to proteomics and microbiomics and has developed a set of multi-omics integrated analysis solutions.
Sequanta Technologies is at the forefront of tumor immunity, cell and gene therapies and is committed to providing supportive services for pathogenesis study, target and biomarker discovery, and standardized tests to pharmaceutical companies, biotechnology companies, and academic research institutions at preclinical study, clinical trial, and post-marketing stages.
描述
  • 600000+
    Various types of samples
  • 1000+
    Project experience
  • 800+
    Establish cooperation with research institutes, pharmaceutical companies, and biotechnology firms
  • 100+
    Types of covered diseases
Our advantages
A diversified experimental platform that meets the requirements of cutting-edge pipeline research and development.
Sequanta Technologies is located in Shanghai and has a central laboratory covering an area of 3000 square meters. It is equipped with a comprehensive set of multi-omics technology platforms, providing one-stop support services for various omics research, including genomics, transcriptomics, proteomics, and microbiomics. With over 300 professional tests, our laboratory is capable of conducting testing services for multiple sample types and interdisciplinary fields simultaneously. We utilize high-throughput automated workstations to process large-scale samples in parallel, ensuring high-quality data and timely delivery.
描述
Quality specification system certified by domestic and international authorities
Sequanta Technologies’ biological laboratory has a comprehensive and multi-level quality management system, covering all quality standards from research and development to production and certification, as well as sample management and data security. We provide customers with report formats and archived documents that meet different quality requirements. We strictly comply with domestic and international laws, regulations, and industry standards, and establish a quality management process that covers the entire life cycle from samples to data, ensuring the compliance of project application.
Providing multiple-discipline integrated solutions for popular application scenarios.
Sequanta Technologies is dedicated to gathering top talents from the industry. Our core R&D team is composed of experts from various fields, including molecular biology, bioinformatics, immunology, and others, who are graduates from well-known universities both domestically and abroad. We utilize a range of omics technologies, such as genomics, transcriptomics, proteomics, and microbiomics, to conduct in-depth research for specific hot application scenarios. We provide multi-disciplinary solutions design and integrated data analysis, helping our partners achieve groundbreaking progress in various fields, such as tumor immunology, cell and gene therapy, vaccine R&D and production, and animal model research.
Efficient project management
The Sequanta Technologies project management team is committed to providing comprehensive, efficient, and quality-controlled high-standard project lifecycle management services for partners from drug discovery to post-market research. Xuzhenda provides each project with a dedicated project manager who responds to customer needs promptly, efficiently integrates project resources, improves information exchange efficiency, and ensures timely delivery of key milestones and smooth implementation of the overall project.
Rich project experience
> 1,000,000 samples of various types
> 1,000 projects
> 1,000 partners including research institutes, pharmaceutical enterprises and biotechnology companies
> 100 types of covered diseases